| Metric | FY2026 | FY2025 | FY2023 | FY2022 | FY2021 | FY2021 | FY2020 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenues | $17.17B+3.1% | $16.66B+7.9% | $15.44B+7.2% | $14.40B+4.8% | $13.74B+11.7% | $12.30B+10.8% | $11.09B+8.8% | $10.19B+0.2% | $10.17B |
| Cost of revenues | $14.07B+1.5% | $13.86B+5.1% | $13.19B+7.2% | $12.31B+5.0% | $11.72B+11.0% | $10.56B+10.6% | $9.55B+9.9% | $8.69B-0.5% | $8.74B |
| Selling, general and administrative expenses | $999.0M+1.6% | $983.0M+4.4% | $942.0M-0.9% | $951.0M+11.8% | $851.0M+10.5% | $770.0M+11.8% | $689.0M-5.5% | $729.0M-1.1% | $737.0M |
| Acquisition, integration and restructuring costs | $18.0M+12.5% | $16.0M-33.3% | $24.0M+41.2% | $17.0M-37.0% | $27.0M-30.8% | $39.0M+680.0% | $5.0M-86.5% | $37.0M-73.4% | $139.0M |
| Goodwill impairment charges | $0 | $0-100.0% | $596.0M | $0 | $0 | — | — | — | — |
| Asset impairment charges | $5.0M-54.5% | $11.0M-87.9% | $91.0M+127.5% | $40.0M+900.0% | $4.0M-66.7% | $12.0M | $0-100.0% | $7.0M | $0 |
| Equity earnings of non-consolidated subsidiaries | -$32.0M+17.9% | -$39.0M-30.0% | -$30.0M-150.0% | -$12.0M+40.0% | -$20.0M-42.9% | -$14.0M+22.2% | -$18.0M+0.0% | -$18.0M-38.5% | -$13.0M |
| Operating income | $2.11B+15.4% | $1.83B+194.2% | $621.0M-42.9% | $1.09B-5.6% | $1.15B+15.4% | $998.0M+9.4% | $912.0M+21.8% | $749.0M+34.0% | $559.0M |
| Interest expense, net | -$203.0M-5.2% | -$193.0M+9.0% | -$212.0M-6.5% | -$199.0M-8.2% | -$184.0M-2.8% | -$179.0M-34.6% | -$133.0M+3.6% | -$138.0M+1.4% | -$140.0M |
| Other income (expense), net | $3.0M-40.0% | $5.0M+183.3% | -$6.0M-100.0% | -$3.0M-200.0% | -$1.0M+97.4% | -$38.0M-143.7% | $87.0M+8800.0% | -$1.0M+96.2% | -$26.0M |
| Income before income taxes | $1.91B+16.5% | $1.64B+306.7% | $403.0M-54.5% | $886.0M-8.4% | $967.0M+23.8% | $781.0M-9.8% | $866.0M+42.0% | $610.0M+55.2% | $393.0M |
| Income tax expense | -$447.0M-15.2% | -$388.0M-99.0% | -$195.0M-1.0% | -$193.0M+7.2% | -$208.0M-36.8% | -$152.0M+22.4% | -$196.0M-600.0% | -$28.0M+3.4% | -$29.0M |
| Net income | $1.46B+16.9% | $1.25B+501.4% | $208.0M-70.0% | $693.0M-8.7% | $759.0M+20.7% | $629.0M-6.1% | $670.0M+15.1% | $582.0M+59.9% | $364.0M |
| Less: net income (loss) attributable to non-controlling interest | $14.0M+566.7% | -$3.0M-133.3% | $9.0M+12.5% | $8.0M+33.3% | $6.0M+500.0% | $1.0M-66.7% | $3.0M+200.0% | $1.0M+150.0% | -$2.0M |
| Net income attributable to Leidos common stockholders | $1.45B+15.5% | $1.25B+530.2% | $199.0M-70.9% | $685.0M-9.0% | $753.0M+19.9% | $628.0M-5.8% | $667.0M+14.8% | $581.0M+58.7% | $366.0M |
| Basic (in dollars per share) | $11310000.00+20.8% | $9360000.00+545.5% | $1450000.00-71.0% | $5000000.00-6.4% | $5340000.00+20.8% | $4420000.00-5.2% | $4660000.00+21.0% | $3850000.00+59.8% | $2410000.00 |
| Diluted (in dollars per share) | $11140000.00+20.8% | $9220000.00+540.3% | $1440000.00-71.0% | $4960000.00-5.9% | $5270000.00+20.9% | $4360000.00-5.2% | $4600000.00+21.1% | $3800000.00+59.7% | $2380000.00 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.